Tyers Asset Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Tyers Asset Management’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$136K	Buy	10,528 +320	+3%	+$3.86K	﹤0.01%	791
2019 Q2	$127K	Hold	10,208	–	–	﹤0.01%	821
2019 Q1	$148K	Buy	10,208 +48	+0.5%	+$613	0.01%	780
2018 Q4	$112K	Buy	10,160 +3,104	+44%	+$43.2K	﹤0.01%	793
2018 Q3	$186K	Buy	7,056 +992	+16%	+$26.8K	0.01%	771
2018 Q2	$124K	Hold	6,064	–	–	﹤0.01%	805
2018 Q1	$110K	Buy	6,064 +32	+0.5%	+$533	﹤0.01%	824
2017 Q4	$84K	Buy	6,032 +416	+7%	+$5.62K	﹤0.01%	887
2017 Q3	$104K	Buy	5,616 +1,712	+44%	+$28.6K	﹤0.01%	808
2017 Q2	$66K	Buy	3,904 +2,016	+107%	+$30.7K	﹤0.01%	868
2017 Q1	$25K	Sell	1,888 -352	-16%	-$5.51K	﹤0.01%	933
2016 Q4	$34K	Buy	+2,240	New	+$29.6K	﹤0.01%	854

Other funds holding MNTA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Tyers Asset Management's MNTA Position: Q3 2019 in Review

Tyers Asset Management increased its Momenta Pharmaceuticals, Inc. (MNTA) stake by 3.1% in Q3 2019, buying an estimated $3.86K and bringing the position to 10,528 shares worth $136K. The position accounts for ﹤0.01% of the portfolio, ranked #791.

Tyers Asset Management first reported a position in MNTA in Q4 2016 and has held it in 12 quarters since. The position peaked at $186K in Q3 2018. 154 funds tracked by Wall St. Rank hold MNTA as of Q3 2019.

Tyers Asset Management held 10,528 shares of Momenta Pharmaceuticals, Inc. worth $136K as of Q3 2019.
Tyers Asset Management bought 320 Momenta Pharmaceuticals, Inc. shares in Q3 2019, an estimated $3.86K.
Momenta Pharmaceuticals, Inc. made up ﹤0.01% of Tyers Asset Management's portfolio in Q3 2019, its #791 holding.
Tyers Asset Management first reported a position in Momenta Pharmaceuticals, Inc. in Q4 2016 and has held it in 12 quarters since.
Tyers Asset Management's Momenta Pharmaceuticals, Inc. position peaked at $186K in Q3 2018.
154 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2019.

Based on Tyers Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.